Paxman writes, “When Real Housewives of Miami star Guerdy Abraira recently proclaimed “Chemo Starts Now” after shaving off her hair before starting her treatment for breast cancer in People Magazine1, this made me realize just how little the general public and even celebrities like Abraria know about the medical technology being utilized today, such as scalp cooling systems, to manage and prevent chemotherapy-induced hair loss.” Read to learn more.

Sherif Sultan writes, “Artificial intelligence momentum will transform and disrupt how medicine works. The application of AI to a cardiovascular health strategy offers limitless opportunities as it provides a continuous source of data-driven insights to optimize biomedical research, precision imaging, early public health primary intervention, and overall superior healthcare quality improvement.” Read on.

Brian Pedlar, CEO of Covalon Technologies writes, A simple dressing application holds the power to both heal and harm. However, beneath their seemingly straightforward design exists a realm of concerns. When the wrong dressing is used it can cause significant harm affecting everyone from the tiniest of babies in the NICU to vulnerable adults, clinicians, caregivers, and even hospital administration.” Read more what he has to say.

Harvey writes, “When we looked at cybersecurity and medical devices last fall, the Food and Drug Administration (FDA) did not have express federal statutory requirements for medical device manufacturers regarding cybersecurity. However, it is clear that there are real dangers. In September 2022, the Federal Bureau of Investigation (FBI) reported that as of January 2022, 53% of connected medical devices and other Internet of things (IoT) devices in hospitals had known critical vulnerabilities.” Read on.

Christopher Cauble writes, “There are many risks and a few rewards to an intellectual property strategy that foregoes patent protection in non-U.S. jurisdictions. Startups or midsize medical device companies should include intellectual property specialists in strategy sessions for market development.” Read to learn more.

Luka Yancopoulos writes: “There’s a lingering issue in the healthcare sector that doesn’t get the attention it deserves, and it’s not directly related to patient care or medication breakthroughs. Instead, it revolves around the supply chain – the backbone of the healthcare industry that ensures critical medical supplies get from manufacturers to end-users.” Read on to learn more.